Comparison of the efficacy and safety of oligomeric proanthocyanidins and nifedipine in patients with primary Raynaud's phenomenon: An open-label, randomized, prospective pilot study
Arch Rheumatol. 2022 Nov 4;38(3):477-479.
doi: 10.46497/ArchRheumatol.2023.9212.
eCollection 2023 Sep.
1 Division of Rheumatology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Republic of Korea.